Biggest News Aggregation in the World
📰 Source Solutions News

Page 7 - Source Solutions News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Source Solutions. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Global Blood Therapeutics : Oxbryta® (voxelotor) Tablets for Oral Suspension, A New Dispersible Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the United States - Form 8-K

Oxbryta® Tablets for Oral Suspension, A New Dispersible Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the United States SOUTH SAN FRANCISCO,... | January 10, 2022
Ministry Of Health United Arab Emirates United States United Kingdom Kim Smith Whitley Steven Immergut

U.S. FDA Approves Supplemental New Drug Application for Expanded Indication of Oxbryta (voxelotor) for Children as Young as 4 Years of Age with Sickle Cell Disease

17.12.2021 - New dispersible tablet dosage form also approved Oxbryta is the first medicine that addresses the root cause of red blood cell sickling SOUTH SAN FRANCISCO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) - Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ...
Ministry Of Health United Arab Emirates United States United Kingdom Steven Immergut Lewis Hsu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science